Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Mucosal immunoglobulin A in HIV-exposed seronegative individuals.

Trabattoni D, Biasin M, Clerici M.

AIDS. 2012 Nov 13;26(17):2247-50. doi: 10.1097/QAD.0b013e32835848ee. No abstract available.

PMID:
23123517
2.

Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples.

Choi RY, Levinson P, Guthrie BL, Lohman-Payne B, Bosire R, Liu AY, Hirbod T, Kiarie J, Overbaugh J, John-Stewart G, Broliden K, Farquhar C.

AIDS. 2012 Nov 13;26(17):2155-63. doi: 10.1097/QAD.0b013e328359b99b.

3.

Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate.

Devito C, Hinkula J, Kaul R, Lopalco L, Bwayo JJ, Plummer F, Clerici M, Broliden K.

AIDS. 2000 Sep 8;14(13):1917-20.

PMID:
10997395
4.

HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis.

Tudor D, Derrien M, Diomede L, Drillet AS, Houimel M, Moog C, Reynes JM, Lopalco L, Bomsel M.

Mucosal Immunol. 2009 Sep;2(5):412-26. doi: 10.1038/mi.2009.89. Epub 2009 Jul 8.

PMID:
19587640
5.

Orally exposed uninfected individuals have systemic anti-HIV responses associating with partners' viral load.

Hasselrot K, Bratt G, Hirbod T, Säberg P, Ehnlund M, Lopalco L, Sandström E, Broliden K.

AIDS. 2010 Jan 2;24(1):35-43. doi: 10.1097/QAD.0b013e3283329853.

PMID:
19779318
6.

Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.

Bélec L, Ghys PD, Hocini H, Nkengasong JN, Tranchot-Diallo J, Diallo MO, Ettiègne-Traore V, Maurice C, Becquart P, Matta M, Si-Mohamed A, Chomont N, Coulibaly IM, Wiktor SZ, Kazatchkine MD.

J Infect Dis. 2001 Dec 1;184(11):1412-22. Epub 2001 Nov 13.

7.

HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals.

Mazzoli S, Trabattoni D, Lo Caputo S, Piconi S, Blé C, Meacci F, Ruzzante S, Salvi A, Semplici F, Longhi R, Fusi ML, Tofani N, Biasin M, Villa ML, Mazzotta F, Clerici M.

Nat Med. 1997 Nov;3(11):1250-7.

PMID:
9359700
8.

Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Côte d'Ivoire.

Ghys PD, Bélec L, Diallo MO, Ettiègne-Traoré V, Becquart P, Maurice C, Nkengasong JN, Coulibaly IM, Greenberg AE, Laga M, Wiktor SZ.

AIDS. 2000 Nov 10;14(16):2603-8.

PMID:
11101074
9.

Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.

Devito C, Hinkula J, Kaul R, Kimani J, Kiama P, Lopalco L, Barass C, Piconi S, Trabattoni D, Bwayo JJ, Plummer F, Clerici M, Broliden K.

J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):413-20.

PMID:
12138348
10.

Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group.

Beyrer C, Artenstein AW, Rugpao S, Stephens H, VanCott TC, Robb ML, Rinkaew M, Birx DL, Khamboonruang C, Zimmerman PA, Nelson KE, Natpratan C.

J Infect Dis. 1999 Jan;179(1):59-67.

11.

Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.

Mazzoli S, Lopalco L, Salvi A, Trabattoni D, Lo Caputo S, Semplici F, Biasin M, Bl C, Cosma A, Pastori C, Meacci F, Mazzotta F, Villa ML, Siccardi AG, Clerici M.

J Infect Dis. 1999 Sep;180(3):871-5.

13.

Salivary basic proline-rich proteins are elevated in HIV-exposed seronegative men who have sex with men.

Burgener A, Mogk K, Westmacott G, Plummer F, Ball B, Broliden K, Hasselrot K.

AIDS. 2012 Sep 24;26(15):1857-67.

PMID:
22824632
14.

Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.

Fiore JR, Laddago V, Lepera A, La Grasta L, Di Stefano M, Saracino A, Lopalco P, Pastore G, Angarano G.

New Microbiol. 2000 Jan;23(1):85-92.

PMID:
10946410
15.

HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers.

Kaul R, Trabattoni D, Bwayo JJ, Arienti D, Zagliani A, Mwangi FM, Kariuki C, Ngugi EN, MacDonald KS, Ball TB, Clerici M, Plummer FA.

AIDS. 1999 Jan 14;13(1):23-9.

PMID:
10207541
16.

Plasma and mucosal fluid from HIV type 1-infected patients but not from HIV type 1-exposed uninfected subjects prevent HIV type 1-exposed DC from infecting other target cells.

Söderlund J, Hirbod T, Smed-Sörensen A, Johansson U, Kimani J, Plummer F, Spetz AL, Andersson J, Kaul R, Broliden K.

AIDS Res Hum Retroviruses. 2007 Jan;23(1):101-6. Erratum in: AIDS Res Hum Retroviruses. 2007 Mar;23(3):486.

PMID:
17263639
18.

Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.

Ghosh M, Fahey JV, Shen Z, Lahey T, Cu-Uvin S, Wu Z, Mayer K, Wright PF, Kappes JC, Ochsenbauer C, Wira CR.

PLoS One. 2010 Jun 29;5(6):e11366. doi: 10.1371/journal.pone.0011366.

19.
20.

HIV-specific IgG in cervicovaginal secretions of exposed HIV-uninfected female sexual partners of HIV-infected men.

Buchacz K, Parekh BS, Padian NS, van der Straten A, Phillips S, Jonte J, Holmberg SD.

AIDS Res Hum Retroviruses. 2001 Dec 10;17(18):1689-93.

PMID:
11788020
Items per page

Supplemental Content

Write to the Help Desk